|
|
|
Volumn 26, Issue 1 SUPPL. 5, 1999, Pages 13-20
|
|
Irinotecan versus infusional 5-fluorouracil: A phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FLUOROURACIL;
IRINOTECAN;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE COURSE;
DRUG EFFICACY;
DRUG MEGADOSE;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NEUTROPENIA;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
VOMITING;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CAMPTOTHECIN;
COLORECTAL NEOPLASMS;
DNA TOPOISOMERASES, TYPE I;
FEMALE;
FLUOROURACIL;
HUMANS;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
NEOPLASM METASTASIS;
QUALITY OF LIFE;
SURVIVAL ANALYSIS;
TREATMENT FAILURE;
|
|
EID: 0033004104
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (42)
|
|
References (27)
|
